Source:http://linkedlifedata.com/resource/pubmed/id/15971430
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2005-6-23
|
| pubmed:abstractText |
Skin disease can be one of the most refractory clinical manifestations of systemic lupus erythematosus (SLE). The standard therapy consists of sunscreens, topical corticosteroids and antimalarials. However in difficult cases a variety of other drugs have been tried. Here we describe our clinical experience with mycophenolate mofetil (MMF) in patients with cutaneous manifestations of SLE.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0392-856X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
23
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
393-6
|
| pubmed:meshHeading |
pubmed-meshheading:15971430-Adolescent,
pubmed-meshheading:15971430-Adult,
pubmed-meshheading:15971430-Dermatologic Agents,
pubmed-meshheading:15971430-Female,
pubmed-meshheading:15971430-Humans,
pubmed-meshheading:15971430-Lupus Erythematosus, Cutaneous,
pubmed-meshheading:15971430-Male,
pubmed-meshheading:15971430-Middle Aged,
pubmed-meshheading:15971430-Mycophenolic Acid,
pubmed-meshheading:15971430-Retrospective Studies,
pubmed-meshheading:15971430-Treatment Failure
|
| pubmed:articleTitle |
Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil.
|
| pubmed:affiliation |
Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, Lambeth Palace Road, London, United Kingdom. ceciliapisoni@yahoo.com.ar
|
| pubmed:publicationType |
Journal Article
|